Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors

Wayne L. Furman, Fariba Navid, Najat C. Daw, M. Beth McCarville, Lisa M. McGregor, Sheri L. Spunt, Carlos Rodriguez-Galindo, John C. Panetta, Kristine R. Crews, Jianrong Wu, Amar J. Gajjar, Peter J. Houghton, Victor M. Santana, Clinton F. Stewart

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors'. Together they form a unique fingerprint.

Chemistry

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology